Vanda Pharmaceuticals | VNDA - Action





Action Changement Date
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
Agios Pharmaceuticals USD 35.75M 665K 2026-06
Akebia Therapeutics USD 13.02M 22K 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Anika Therapeutics USD 28.56M 5.73M 2026-06
Arrowhead Research USD -173.08M 173.08M 2024-12
AstraZeneca USD 6.93B 362M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
Halozyme Therapeutics USD 137.14M 18.33M 2026-06
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 142.38M 9.48M 2026-06
J&J USD 15.14B 561M 2026-06
Lexicon Pharmaceuticals USD 276K 5K 2026-03
Ligand Pharmaceuticals USD 10.26M 3M 2026-06
Merck USD 6.21B 272M 2026-06
Moderna USD 280M 134M 2026-06
Novartis USD 6.29B 135M 2026-03
Pfizer USD 9.94B 722M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Puma Biotechnology USD 9.48M 885K 2025-09
Sanofi EUR 24.12B 620M 2026-06
Takeda JPY 1.45T 50.64B 2026-06
Teva Pharmaceutical Industries USD 3.18B 3M 2026-03
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
Vanda Pharmaceuticals USD 1.85M 190K 2025-12
Veracyte USD 22.66M 1.24M 2026-06